Resultados da busca - Edward C. Keystone

Modified Disease Activity Score at 3 Months Is a Significant Predictor for Rapid Radiographic Progression at 12 Months Compared With Other Measures in Patients With Rheumatoid Arth... por Mohammad Movahedi, Deborah Weber, Pooneh Akhavan, Edward C. Keystone

Obter o texto integral

Discontinuation of tofacitinib and TNF inhibitors in patients with rheumatoid arthritis: analysis of pooled data from two registries in Canada por Mohammad Movahedi, Angela Cesta, Claire Bombardier, Edward C Keystone, Denis Choquette, Xiuying Li, Louis Coupal, OBRI Investigators

Obter o texto integral

Multiparameter phospho-flow analysis of lymphocytes in early rheumatoid arthritis: implications for diagnosis and monitoring drug therapy. por Carole L Galligan, Janet C Siebert, Katherine A Siminovitch, Edward C Keystone, Vivian Bykerk, Omar D Perez, Eleanor N Fish

Obter o texto integral

Tofacitinib Safety and Effectiveness in Canadian Patients with Rheumatoid Arthritis by Cardiovascular Risk Enrichment: Subanalysis of the CANTORAL Study por Boulos Haraoui, Majed Khraishi, Denis Choquette, Isabelle Fortin, Cassandra D. Kinch, Corina Galos, Patrice Roy, David Gruben, Julie Vaillancourt, John S. Sampalis, Edward C. Keystone

Obter o texto integral

Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis por Josef S. Smolen, Young Mo Kang, Wan-Hee Yoo, Paul Emery, Michael E. Weinblatt, Edward C. Keystone, Mark C. Genovese, Gihyun Myung, Inyoung Baek, Jeehoon Ghil

Obter o texto integral

Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib por Inmaculada de la Torre, Masayoshi Harigai, Joel M Kremer, Edward C Keystone, Maher Issa, Christina Dickson, Josh Rancourt, Thomas Melby, Yoshitaka Isaka, Anabela Cardoso, Chadi Saifan

Obter o texto integral

Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b... por Boulos Haraoui, Janet Pope, Edward C Keystone, Eduardo Mysler, Tatjana Lukic, Harry Shi, Stanley B Cohen, Rebecca Germino, Lori Stockert, Annette Diehl, Sujatha Menon, Shixue Liu

Obter o texto integral

Predictors of Influenza Vaccination in Early Rheumatoid Arthritis 2017‐2021: Results From the Canadian Early Arthritis Cohort por Viviane Ta, Orit Schieir, Marie‐France Valois, Ines Colmegna, Carol Hitchon, Louis Bessette, Glen Hazlewood, Carter Thorne, Janet Pope, Gilles Boire, Diane Tin, Edward C. Keystone, Vivian P. Bykerk, Susan J. Bartlett

Obter o texto integral

A Bridge Too Far? Real‐World Practice Patterns of Early Glucocorticoid Use in the Canadian Early Arthritis Cohort por Kathleen M. Andersen, Orit Schieir, Marie‐France Valois, Susan J. Bartlett, Louis Bessette, Gilles Boire, Boulos Haraoui, Glen Hazlewood, Carol Hitchon, Edward C. Keystone, Janet Pope, Diane Tin, J Carter Throne, Vivian P. Bykerk, CATCH Investigators

Obter o texto integral

Heterogeneous Disease Trajectories Explain Variable Radiographic, Function and Quality of Life Outcomes in the Canadian Early Arthritis Cohort (CATCH). por Cheryl Barnabe, Ye Sun, Gilles Boire, Carol A Hitchon, Boulos Haraoui, J Carter Thorne, Diane Tin, Désirée van der Heijde, Jeffrey R Curtis, Shahin Jamal, Janet E Pope, Edward C Keystone, Susan Bartlett, Vivian P Bykerk, CATCH Investigators

Obter o texto integral